German pharmaceutical company Boehringer Ingelheim is partnering with medication management platform Medisafe to integrate specific information about anticoagulant medication Pradaxa in its app. The move follows a successful pilot and will offer Pradaxa patients in the Brazil access to features including adherence and biometric tracking and Medisafe's alert service MedFriend. The agreement follows a similar partnership with Merck that's being rolling out in US, Mexico and Russia.
German pharmaceutical company Boehringer Ingelheim is partnering with medication management platform Medisafe to integrate specific information about anticoagulant medication Pradaxa in its app. The move follows a successful pilot and will offer Pradaxa patients in the US access to features including adherence and biometric tracking and Medisafe's alert service MedFriend. The agreement follows a similar partnership with Merck that's being rolling out in Brazil, Mexico and Russia.